RESUMEN
OBJECTIVE: To describe a new spinocerebellar ataxia (SCA48) characterized by early cerebellar cognitive-affective syndrome (CCAS) and late-onset SCA. METHODS: This is a descriptive study of a family that has been followed for more than a decade with periodic neurologic and neuropsychological examinations, MRI, brain SPECT perfusion, and genetic analysis. Whole exome sequencing was performed in 3 affected and 1 unaffected family member and subsequently validated by linkage analysis of chromosome 16p13.3. RESULTS: Six patients fully developed cognitive-affective and complete motor cerebellar syndrome associated with vermian and hemispheric cerebellar atrophy, suggesting a continuum from a dysexecutive syndrome slowly evolving to a complete and severe CCAS with late truncal ataxia. Three presymptomatic patients showed focal cerebellar atrophy in the vermian, paravermian, and the medial part of cerebellar lobes VI and VII, suggesting that cerebellar atrophy preceded the ataxia, and that the neurodegeneration begins in cerebellar areas related to cognition and emotion, spreading later to the whole cerebellum. Among the candidate variants, only the frameshift heterozygous c.823_824delCT STUB1 (p.L275Dfs*16) pathogenic variant cosegregated with the disease. The p.L275Dfs*16 heterozygous STUB1 pathogenic variant leads to neurodegeneration and atrophy in cognition- and emotion-related cerebellar areas and reinforces the importance of STUB1 in maintaining cognitive cerebellar function. CONCLUSIONS: We report a heterozygous STUB1 pathogenic genetic variant causing dominant cerebellar ataxia. Since recessive mutations in STUB1 gene have been previously associated with SCAR16, these findings suggest a previously undescribed SCA locus (SCA48; MIM# 618093).
Asunto(s)
Ataxias Espinocerebelosas/genética , Ataxias Espinocerebelosas/patología , Ubiquitina-Proteína Ligasas/genética , Adulto , Femenino , Heterocigoto , Humanos , Masculino , Persona de Mediana Edad , Mutación , Linaje , EspañaRESUMEN
PURPOSE: Evidence of whether the recent economic crisis has or has not had an effect on psychotropic drug consumption is very scarce. Our objective was to determine if there had in fact been an increase in psychotropic drug use as a result of the financial crisis. METHODS: In our study a retrospective cohort (between January 1, 2005, and December 31, 2012) was made up of individuals from the general population in a region in the northeast of Catalonia, Spain. We specified a generalized linear mixed model along with combined 'selection on observables' as (propensity scoring) matching and 'selection on unobservables' as (random coefficient) the panel data model methods, and performed inferences using a Bayesian framework. RESULTS: In the period following the economic crisis (post 2009), there was an increase in the consumption of psychotropic drugs which was significantly higher among those who had already been consuming psychotropic drugs prior to 2009 and those most likely to be unemployed. The increase was of greater significance when consumption was measured by the number of drugs being taken, rather than by the defined daily dose (DDD), with the greatest increase occurring in 2011; the very year in which Spain was most affected by the crisis. CONCLUSIONS: Once the financial crisis had ended, there was an increase in the severity, rather than the intensity, of mental health disorders in individuals who had already had disorders before the crisis. This increase occurred in those most likely to be unemployed, and the severity was accentuated in the toughest year of the economic crisis.
Asunto(s)
Depresión/tratamiento farmacológico , Utilización de Medicamentos/estadística & datos numéricos , Recesión Económica , Trastornos Psicóticos/tratamiento farmacológico , Psicotrópicos/uso terapéutico , Desempleo/psicología , Adolescente , Adulto , Anciano , Teorema de Bayes , Depresión/economía , Depresión/epidemiología , Depresión/fisiopatología , Utilización de Medicamentos/economía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Trastornos Psicóticos/economía , Trastornos Psicóticos/epidemiología , Trastornos Psicóticos/fisiopatología , Psicotrópicos/economía , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , España/epidemiología , Desempleo/estadística & datos numéricosRESUMEN
El trastorno por estrés postraumático (TEPT) aparece de forma comórbida con el trastorno mental grave (TMG) en el 1648% de los casos, una cifra mucho más alta que en la población general (7,89,2%). Aunque en estos pacientes con enfermedad psiquiátrica primaria grave el diagnóstico del TEPT es muy frecuentemente obviado. Hay varias hipótesis etiopatogénicas que explicarían la alta prevalencia de TEPT en pacientes con TMG: diátesis del propio trauma; alto riesgo de exposición a situaciones traumáticas; predisposición genética para la psicosis en un grupo de pacientes con TEPT, y efecto del propio tratamiento antidopaminérgico. Las repercusiones del TEPT en pacientes con TMG están bien documentadas en la bibliografía. Los pacientes con TEPT presentan síntomas psiquiátricos más severos, más trastornos por abuso de alcohol y otras sustancias, tienen un mayor número de visitas y hospitalizaciones psiquiátricas, una menor integración laboral, una peor adherencia al tratamiento farmacológico, más conductas de riesgo, intentos de suicidio y autolesiones, y una función cognitiva más pobre. Los antidepresivos, en especial los inhibidores selectivos de la recaptación de serotonina, y la terapia cognitivo conductual serían los tratamientos de elección en el TEPT. Los últimos estudios indican que la terapia cognitivo conductual podría ser también útil en los síntomas postraumáticos de pacientes afectados de TMG. En la práctica clínica es recomendable realizar de forma sistemática una valoración de los traumas sufridos e indagar acerca de la existencia de síntomas postraumáticos en las entrevistas clínicas (AU)
Posttraumatic stress disorder (PTSD) appears by comorbid severe mental illness (SMI) in 16%48% of cases, higher than in the general population (7.8% to 9.2%). Although these patients with severe primary psychiatric diagnosis of PTSD is often missed. Several etiopathogenic hypotheses could explain the high prevalence of PTSD in patients with SMI: diathesis trauma itself, a high risk of exposure to trauma, genetic predisposition to psychosis in a group of patients with PTSD and antidopaminergic effect of treatment itself. The impact of PTSD in patients with SMI is well documented in the literature. PTSD patients with more severe psychiatric symptoms, more alcohol use disorders and other substances, have a greater number of visits and psychiatric hospitalizations, lower work integration, poorer adherence to drug treatment, more risk behaviours, suicide attempts and self-harm, and poorer cognitive function. Antidepressants especially selective serotonin reuptake of serotonin and cognitive behavioral therapy would be the treatments of choice in PTSD. Recent studies indicate that cognitive behavioral therapy may also be useful in post-traumatic symptoms of patients with SMI. In clinical practice it is advisable to systematically perform an assessment of the traumas and investigate the existence of PTSD symptoms in clinical interviews (AU)